Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6470554

COc1ccc2nc(Nc3nc(O)c4cc(N)cc(C)c4n3)nc(C)c2c1.O=C(O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.46
TDP2 O95551 1/20 0.44
ALDH1A1 P00352 10/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
USP2 O75604 2/20 0.44
RAB9A P51151 2/20 0.44
LMNA P02545 2/20 0.44
MAPT P10636 8/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
TSHR P16473 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HTT P42858 1/20 0.41
HSD17B10 Q99714 2/20 0.41
POLB P06746 1/20 0.41
HPGD P15428 3/20 0.40
ALOX12 P18054 2/20 0.40
NPC1 O15118 1/20 0.40
HIF1A Q16665 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6467460 0.92 KDM4E (0.45) KDM4ETDP2ALDH1A1L3MBTL1MEN1
Trifluoroacetic Acid SCHEMBL6469682 0.90 KDM4E (0.39) KDM4ETDP2ALDH1A1L3MBTL1MEN1
Trifluoroacetic Acid SCHEMBL6469262 0.90 TDP2 (0.48) KDM4ETDP2ALDH1A1L3MBTL1MEN1
Trifluoroacetic Acid SCHEMBL6469598 0.88 MAPT (0.41) KDM4EALDH1A1MEN1KMT2AMAPT
Trifluoroacetic Acid SCHEMBL6465684 0.87 KMT2A (0.33) KDM4ETDP2ALDH1A1L3MBTL1MEN1
SCHEMBL6470555 0.86 KDM4E (0.44) KDM4ETDP2ALDH1A1L3MBTL1MEN1
Trifluoroacetic Acid SCHEMBL6465735 0.85 ALDH1A1 (0.46) KDM4ETDP2ALDH1A1L3MBTL1MEN1
Trifluoroacetic Acid SCHEMBL6466210 0.85 SRC (0.39) KDM4EALDH1A1MEN1KMT2AUSP2
Trifluoroacetic Acid SCHEMBL6470388 0.84 TDP2 (0.44) KDM4ETDP2ALDH1A1L3MBTL1MEN1
Trifluoroacetic Acid SCHEMBL6467058 0.84 TDP2 (0.44) KDM4ETDP2ALDH1A1L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections REPLIDYNE, INC. 2005-06-09 US claimed
WO-2005030131-A2 BIS-QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS REPLIDYNE, INC (US) 2005-04-07 WO claimed
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections REPLIDYNE, INC. 2005-06-09 US disclosed
WO-2005030131-A2 BIS-QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS REPLIDYNE, INC (US) 2005-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections POLI, POLK, POLB KDM4E 3225/4885TDP2 424/4885ALDH1A1 3154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.